AMEX : IHE

iShares U.S. Pharmaceuticals ETF

$103.86 USD

$1.39 (1.36%)

Volume
147.46K
Average Volume
190.23K
Market Capitalization
$1.18B
P/E Ratio
Dividend Yield
%
Price Target
Year High
$105.02
Year Low
$66.50
Day High
—
Day Low
—
Payout Ratio
Current Ratio
Company Overview

AMEX

Asset Management

Financial Services

IHE

N/A

US

USD

https://www.ishares.com/us/products/239519/ishares-us-pharmaceuticals-etf

1-800-474-2737

464288836

0001100663

Liquidity Metrics

Sales & Valuation

-$

Profitability

-$

%

%

%

%

P/E Metrics

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

No financial score data available.

Key Metrics (TTM)

No key metrics data available.

Company Executives

No executive data available.

Poll Results

No votes yet today — be the first to share your view!

About iShares U.S. Pharmaceuticals ETF (AMEX:IHE) Stock

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States. ...

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

2026-08-07 01:15:00

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.

XLV vs. IHE: Which Healthcare ETF Is the Better Buy?

2026-07-31 11:53:28

The Health Care Select Sector SPDR Fund (XLV) carries a significantly lower expense ratio than the iShares U.S. Pharmaceuticals ETF (IHE). IHE concentrates exclusively on the pharmaceutical industry, while XLV spreads its bets across the broader healthcare sector.

Will Generic Drug Tariffs Impact Pharma ETFs?

2026-07-30 09:56:10

New U.S. tariffs on generic drugs could pressure drugmakers and influence pharmaceutical ETFs. Here's what investors should watch.

Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collide

2026-07-30 00:28:48

Asian stocks were mixed on Thursday as investors assessed the fallout from the AI sell-off, the Federal Reserve's rate outlook and renewed tensions in the Middle East. The MSCI Asia-Pacific gauge excluding Japan was little changed after swinging between gains and losses.

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?

2026-07-22 16:33:01

Vanguard Health Care ETF offers a significantly lower expense ratio of 0.09% compared to 0.38% for iShares U.S. Pharmaceuticals ETF iShares U.S. Pharmaceuticals ETF has delivered higher total returns over the last five years but carries higher concentration risk with only 56 holdings Vanguard Health Care ETF provides broader sector diversification by covering the entire medical ecosystem while the iShares fund focuses strictly on drug manufacturers

Kospi jumps 6% as Asia's battered semiconductor trade rebounds

2026-07-22 00:32:10

Asian stocks rallied on Wednesday as investors returned to semiconductor shares after a bruising sell-off, taking their cue from a Wall Street rebound even as Brent crude pushed further above $91 a barrel. MSCI's Asia-Pacific gauge outside Japan gained 1.2%, while South Korea's Kospi surged more than 6% and Japan's Nikkei 225 climbed 1.9%.

IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?

2026-07-19 06:27:50

IHE pays a meaningfully higher dividend yield than BBH. BBH offers more concentrated exposure with 25 holdings, compared to 56 for IHE.

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

2026-07-18 20:16:01

iShares Global Healthcare ETF provides exposure to 110 international stocks, whereas iShares U.S. Pharmaceuticals ETF concentrates on 56 domestic companies iShares U.S. Pharmaceuticals ETF has higher concentration risk with its two largest holdings accounting for over 43.00% of the total portfolio iShares U.S. Pharmaceuticals ETF has outperformed on a one-year and five-year total return basis compared to iShares Global Healthcare ETF

Frequently Asked Questions

What is the current iShares U.S. Pharmaceuticals ETF (IHE) stock price?

iShares U.S. Pharmaceuticals ETF(AMEX:IHE) stock price is $103.86 in the last trading session. During the trading session, IHE stock reached the peak price of $105.02 while $66.5 was the lowest point it dropped to. The percentage change in IHE stock occurred in the recent session was 1.36% while the dollar amount for the price change in IHE stock was $1.39.

IHE's industry and sector of operation?

The AMEX listed IHE is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of IHE?

|
|
|
|
|

How many employees does IHE have?

Number of IHE employees currently stands at None. IHE operates from 400 Howard Street, San Francisco, CA 94105, US.

Link for IHE official website?

Official Website of IHE is: https://www.ishares.com/us/products/239519/ishares-us-pharmaceuticals-etf

How do I contact IHE?

IHE could be contacted at phone #1-800-474-2737 and can also be accessed through its website. IHE operates from 400 Howard Street, San Francisco, CA 94105, US.

How many shares of IHE are traded daily?

The average number of IHE shares traded daily for last 3 months was 190.23K.

What is the market cap of IHE currently?

The market value of IHE currently stands at $1.18B with its latest stock price at $103.86